New hope for painful skin condition: experimental drug enters mid-stage trial

This study tests an experimental drug called SCT650C in 60 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing boils and tunnels. The goal is to see if the drug can reduce abscesses and inflammation by at least 75% after 16 weeks. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor their doctors will know which they receive.